Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, European, Observational, Drug Utilisation Study (DUS) of BLI800 (Eziclen®/Izinova®) as a Bowel Cleansing Preparation

NCT02630680 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02630680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02630680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, European, Observational, Drug Utilisation Study (DUS) of BLI800 (Eziclen®/Izinova®) as a Bowel Cleansing Preparation
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
April 25, 2017
Enrollment
1,286 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

bowel cleansing